A proSpective Randomized Controlled Trial comParing infliximAb-antimetabolites Combination Therapy to Anti-metabolites monotheRapy and Infliximab monothErapy in Crohn's Disease Patients in Sustained Steroid-free Remission on Combination Therapy

CHU LIEGE - Sart Tilman, Liège

Gent University Hospital, Ghent

Caen Unversity Hospital, Caen

Chu Besancon, Besançon

Chu Toulouse, Toulouse

CHU Bordeaux - Pessac, Pessac

Chu Montpellier, Montpellier

Chu Rennes, Rennes

Chu Tours, Tours

Chu Saint Etienne, Saint-Etienne

Chu Nantes, Nantes

Chu Reims, Reims

Chu Nancy, Vandœuvre-lès-Nancy

Chu Lille, Lille

Chr Valencienne, Valenciennes

Chu Clermont-Ferrand, Clermont-Ferrand

CHU LYON, Pierre-Bénite

Hopital Saint Louis, Paris

Hopital St Antoine, Paris

Hopital Saint Joseph, Paris

Montsouris Mutualist Institute, Paris

Chu Amiens, Amiens

Hopital Beaujon, Clichy

Chu Kremlin Bicetre, Le Kremlin-Bicêtre

Hopital Bicetre, Le Kremlin-Bicêtre

St Vincent Hospital, Melbourne

CHU NICE, Nice